(b) any amount raised pursuant to any note purchase facility or the issue of bonds, notes, debentures, loan stock or any similar instrument;
#4677457/1
6(77)
(d) receivables sold or discounted (other than any receivables to the extent they are sold on a non-recourse basis);
(e) any sale and lease-back transaction, or similar transaction which is treated as indebtedness under GAAP;
(f) any liability under a deferred purchase agreement where the deferred payment is arranged primarily as a method of raising finance or financing the acquisition of that asset;
(g) any derivative transaction entered into in connection with protection against or benefit from fluctuation in any rate or price, including without limitation currency or interest rate swaps, caps or collar transactions, (and, when calculating the value of any derivative transaction, only the mark to market value shalL be taken into account);
(h) any amount raised under any other transaction (including any forward sale or purchase agreement) having the commercial effect of a borrowing or raising of money;
(i) any counter-indemnity obligation in respect of a guarantee, indemnity, bond, standby or documentary letter of credit or any other instrument issued by a bank or financial institution in respect of any underlying liability; and
